{
  "openalex_id": "W2224804004",
  "doi": "https://doi.org/10.18632/oncotarget.6734",
  "title": "MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer",
  "abstract": "// Zibing Wang 1, * , Yuqing Liu 2, * , Yong Zhang 1 , Yiman Shang 1 , Quanli Gao 1 1 Department of Immunotherapy, Henan Cancer Hospital and Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China 2 Department of Oncology, Third Affiliated Hospital of Xinxiang Medical College, Xinxiang 453003, China * These authors contributed equally to this work Correspondence to: Quanli Gao, e-mail: gaoquanli1@aliyun.com Zibing Wang, e-mail: bingziwang@hotmail.com Keywords: myeloid-derived suppressor cells, cytokine-induced killer cells, immunotherapy, solid tumors, overall survival Received: June 25, 2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accepted: December 12, 2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Published: December 23, 2015 ABSTRACT Adoptive immunotherapy using cytokine-induced killer (CIK) cells is a promising cancer treatment, but its efficacy is restricted by various factors, including the accumulation of myeloid-derived suppressor cells (MDSCs). In this study, we determine whether chemotherapeutic drugs that reduce MDSC levels enhance the efficacy of CIK cell therapy in the treatment of solid tumors. Fifty-three patients were included in this study; 17 were diagnosed with metastatic renal cell carcinoma (MRCC), 10 with advanced pancreatic cancer (PC), and 26 with metastatic melanoma (MM). These patients were divided into two groups: CIK cell therapy alone and CIK cell therapy combined with chemotherapy. Combining CIK cell therapy and chemotherapy increased 1-year survival rates and median survival times in MRCC and PC patients, but not in MM patients. The disease control rate did not differ between treatment groups for MRCC or MM patients, but was higher in PC patients receiving combined treatment than CIK cell treatment alone. These data suggest that addition of MDSC-decreasing chemotherapy to CIK cell therapy improves survival in MRCC and PC patients.",
  "authors": [
    {
      "display_name": "Zibing Wang",
      "id": "A5041511730",
      "orcid": null,
      "institutions": [
        {
          "id": "I38877650",
          "display_name": "Zhengzhou University",
          "country_code": "CN",
          "type": "funder"
        },
        {
          "id": "I4210143608",
          "display_name": "Henan Cancer Hospital",
          "country_code": "CN",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Zibing Wang"
    },
    {
      "display_name": "Yuqing Liu",
      "id": "A5101927474",
      "orcid": "https://orcid.org/0000-0001-5713-6409",
      "institutions": [
        {
          "id": "I80626142",
          "display_name": "Xinxiang Medical University",
          "country_code": "CN",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Yuqing Liu"
    },
    {
      "display_name": "Yong Zhang",
      "id": "A5100419902",
      "orcid": "https://orcid.org/0009-0004-5226-6422",
      "institutions": [
        {
          "id": "I4210143608",
          "display_name": "Henan Cancer Hospital",
          "country_code": "CN",
          "type": "healthcare"
        },
        {
          "id": "I38877650",
          "display_name": "Zhengzhou University",
          "country_code": "CN",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Yong Zhang"
    },
    {
      "display_name": "Yiman Shang",
      "id": "A5010169890",
      "orcid": "https://orcid.org/0000-0001-6849-4121",
      "institutions": [
        {
          "id": "I4210143608",
          "display_name": "Henan Cancer Hospital",
          "country_code": "CN",
          "type": "healthcare"
        },
        {
          "id": "I38877650",
          "display_name": "Zhengzhou University",
          "country_code": "CN",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Yiman Shang"
    },
    {
      "display_name": "Quanli Gao",
      "id": "A5031523854",
      "orcid": "https://orcid.org/0000-0002-9947-8818",
      "institutions": [
        {
          "id": "I4210143608",
          "display_name": "Henan Cancer Hospital",
          "country_code": "CN",
          "type": "healthcare"
        },
        {
          "id": "I38877650",
          "display_name": "Zhengzhou University",
          "country_code": "CN",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Quanli Gao"
    }
  ],
  "publication_year": 2015,
  "publication_date": "2015-12-23",
  "type": "article",
  "cited_by_count": 61,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S126644158",
    "display_name": "Oncotarget",
    "issn_l": "1949-2553",
    "issn": [
      "1949-2553"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310316297"
  },
  "volume": "7",
  "issue": "4",
  "first_page": "4760",
  "last_page": "4769",
  "open_access": {
    "is_oa": true,
    "oa_status": "gold",
    "oa_url": "http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=6734&path%5B%5D=18864",
    "any_repository_has_fulltext": true
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.8943106
    },
    {
      "id": "C2779109515",
      "display_name": "Cytokine-induced killer cell",
      "level": 5,
      "score": 0.8307839
    },
    {
      "id": "C2777701055",
      "display_name": "Immunotherapy",
      "level": 3,
      "score": 0.71507454
    },
    {
      "id": "C2776694085",
      "display_name": "Chemotherapy",
      "level": 2,
      "score": 0.68579495
    },
    {
      "id": "C2777472916",
      "display_name": "Renal cell carcinoma",
      "level": 2,
      "score": 0.66066325
    },
    {
      "id": "C143998085",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.53743356
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.5125127
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.44815478
    },
    {
      "id": "C10882517",
      "display_name": "Cell therapy",
      "level": 3,
      "score": 0.44180918
    },
    {
      "id": "C1491633281",
      "display_name": "Cell",
      "level": 2,
      "score": 0.42507005
    },
    {
      "id": "C203014093",
      "display_name": "Immunology",
      "level": 1,
      "score": 0.348844
    },
    {
      "id": "C8891405",
      "display_name": "Immune system",
      "level": 2,
      "score": 0.25130016
    },
    {
      "id": "C167672396",
      "display_name": "CD8",
      "level": 3,
      "score": 0.13315082
    },
    {
      "id": "C114684123",
      "display_name": "CD3",
      "level": 4,
      "score": 0.067031294
    },
    {
      "id": "C54355233",
      "display_name": "Genetics",
      "level": 1,
      "score": 0.0
    },
    {
      "id": "C86803240",
      "display_name": "Biology",
      "level": 0,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T11313",
      "display_name": "Immune cells in cancer",
      "score": 0.9971
    },
    {
      "id": "T11020",
      "display_name": "Immune Cell Function and Interaction",
      "score": 0.9965
    },
    {
      "id": "T10158",
      "display_name": "Cancer Immunotherapy and Biomarkers",
      "score": 0.9929
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.18632/oncotarget.6734",
  "pdf_url": "http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=6734&path%5B%5D=18864",
  "retrieved_date": "2025-07-30T16:05:12.022745",
  "source_database": "OpenAlex"
}